Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1975 1
1989 2
1991 1
1992 1
1996 1
1999 1
2003 1
2006 2
2008 1
2009 1
2010 1
2011 2
2012 6
2013 2
2014 4
2017 2
2018 4
2019 6
2020 18
2021 18
2022 24
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma.
Chari A, Minnema MC, Berdeja JG, Oriol A, van de Donk NWCJ, Rodríguez-Otero P, Askari E, Mateos MV, Costa LJ, Caers J, Verona R, Girgis S, Yang S, Goldsmith RB, Yao X, Pillarisetti K, Hilder BW, Russell J, Goldberg JD, Krishnan A. Chari A, et al. Among authors: askari e. N Engl J Med. 2022 Dec 15;387(24):2232-2244. doi: 10.1056/NEJMoa2204591. Epub 2022 Dec 10. N Engl J Med. 2022. PMID: 36507686 Clinical Trial.
NETosis in ischemic/reperfusion injuries: An organ-based review.
Hashemi P, Nouri-Vaskeh M, Alizadeh L, Baghbanzadeh A, Badalzadeh R, Askari E, Baradaran B. Hashemi P, et al. Among authors: askari e. Life Sci. 2022 Feb 1;290:120158. doi: 10.1016/j.lfs.2021.120158. Epub 2021 Nov 23. Life Sci. 2022. PMID: 34822798 Review.
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial.
Dimopoulos M, Sanz RG, Lee HP, Trneny M, Varettoni M, Opat S, D'Sa S, Owen RG, Cull G, Mulligan S, Czyz J, Castillo JJ, Motta M, Siddiqi T, Gironella Mesa M, Granell Gorrochategui M, Talaulikar D, Zinzani PL, Askari E, Grosicki S, Oriol A, Rule S, Kloczko J, Tedeschi A, Buske C, Leblond V, Trotman J, Chan WY, Michel J, Schneider J, Tan Z, Cohen A, Huang J, Tam CS. Dimopoulos M, et al. Among authors: askari e. Blood Adv. 2020 Dec 8;4(23):6009-6018. doi: 10.1182/bloodadvances.2020003010. Blood Adv. 2020. PMID: 33284944 Free PMC article. Clinical Trial.
99mTc-PSMA Left Behind: a Call for Collaboration.
Moghadam SZ, Askari E, Aryana K. Moghadam SZ, et al. Among authors: askari e. Nucl Med Mol Imaging. 2022 Aug;56(4):218-219. doi: 10.1007/s13139-022-00753-7. Epub 2022 Jun 6. Nucl Med Mol Imaging. 2022. PMID: 35846417 No abstract available.
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals.
Marjani M, Tabarsi P, Moniri A, Hashemian SM, Nadji SA, Abtahian Z, Malekmohammad M, Kiani A, Farzanegan B, Eslaminejad A, Fakharian A, Heshmatnia J, Abedini A, Seifi S, Yassari F, Mirenayat MS, Rezaei M, Sheikhzade H, Ahmadi ZH, Dastan F, Sadeghi M, Lookzadeh S, Porabdollah M, Askari E, Baghaei P, Mansourafshar B, Jahangirifard A, Vasheghani M, Mokhber Dezfuli M, Varahram M, Jamaati H, Mansouri D, Zali A, Velayati AA. Marjani M, et al. Among authors: askari e. Tanaffos. 2020 Nov;19(2):91-99. Tanaffos. 2020. PMID: 33262795 Free PMC article. Review. No abstract available.
A comprehensive review of chemokine CXC17 (VCC1) in cancer, infection, and inflammation.
Gowhari Shabgah A, Jadidi-Niaragh F, Ebrahimzadeh F, Mohammadi H, Askari E, Pahlavani N, Malekahmadi M, Ebrahimi Nik M, Gholizadeh Navashenaq J. Gowhari Shabgah A, et al. Among authors: askari e. Cell Biol Int. 2022 Oct;46(10):1557-1570. doi: 10.1002/cbin.11846. Epub 2022 Jul 10. Cell Biol Int. 2022. PMID: 35811438 Review.
95 results